Faecalibacterium prausnitzii

Information

Microbe Identification

Faecalibacterium prausnitzii

Microbe id: PMDBM2020088
Level: Species
NCBI Taxonomy ID:
Taxonomy Species: Faecalibacterium prausnitzii [853]
Taxonomy Genus: Faecalibacterium [216851]
Taxonomy Family: Oscillospiraceae [216572]

Interactions between microbe and active substances


ⓘ How do we work out MGCs and BGCs of one specific species?


Metabolic gene clusters of Faecalibacterium prausnitzii

Identified MGC Region
(click for details)
MGC Cluster (Most Similar) Similarity Compound metabolized by the MGC Type of MGC Reference(PubMed ID)
Unclassified gene clustern.a.Others HGD unassignedPMID: 36782070
Threonine to propionate E. coliAmino acidsTPP AA metabolismPMID: 36782070
Rnf complex C. sporogenesEnergy-capturing-relatedRnf complexPMID: 23269825
Acetate to butyrate C. sporogenesAcetateAcetate to butyratePMID: 17241242
Arginine2putrescine R. gnavusPutrescinePutrescine to spermidinePMID: 30183487
Pyruvate to acetate-formate E. coliPyruvatePyruvate to acetate-formatePMID: 20622067

n.s. indicates that no significant matches were found by KnownClusterBlast.

View gutSMASH Detailed Result
Biosynthetic gene clusters of Faecalibacterium prausnitzii


Identified BGC Region
(click for details)
BGC Cluster (Most Similar) Similarity Compound Synthesized by the BGC Type of BGC Reference (PubMed ID)
Unclassified gene clustern.a.RanthipeptidePMID: 34019648
Unclassified gene clustern.a.Cyclic-lactone-autoinducerPMID: 34019648

n.s. indicates that no significant matches were found by KnownClusterBlast.

View antiSMASH Detailed Result
Map of Faecalibacterium prausnitzii distribution in human body and influence of diseases distribution in human body and influence of diseases


ⓘ How do you use the microbe distribution map?
ⓘ How did we get the relative abundance and microbe change in the map?
bodymap Oral Nose Esophagus Stomach Trachea Upper respiratory tract Vagina Blood Urethral Lung Cervix Rectum Skin Duodenum Fallopian tube Fallopian tube Peritoneal fluid Uterus Ear Ovary Ovary Colon Ileum Cecum
Disease id Bodysite Relative abundance (%) Disease name Microbe_change

Relative abundance landscape of Faecalibacterium prausnitzii in human gut microbiota samples



Abundance lanscape in healthy samples (by patients' age)
Abundance lanscape in healthy samples (by patients' country)
Abundance lanscape in disease samples
⚠ About the relative abundance profile

The relative taxonomical abundance data (pre-processed using a unified analysis pipeline) was retrieved from curatedMetagenomicData resource [Edoardo Pasolli, et al. Nat Methods. 2017;14(11):1023-1024]. Data retrieved here was pre-processed as unified relative abundance: at each taxonomic level (e.g., species, genus, family), the sum of microbial abundance of individual microbiota sample was 1, and relative abundance of each microbe was log10 transformed [relative abundance ranges from -7 to 0].

Healthy samples and disease samples (only disease types with >= 20 samples were included) were grouped by age periods, patients?country, or disease type to plot the relative abundance landscape using ggplot2 R package.



Comparative analysis of human gut metagenomes between disease and healthy samples of Faecalibacterium prausnitzii

Data source: Phenotype comparisons were obtained from GMrepo . We summarized all comparisons that included healthy samples as controls and overlapped with microbes represented in MASI.

Note: LDA scores below 0 indicate taxa enriched in healthy samples, whereas scores above 0 indicate taxa enriched in disease samples.

Disease Project ID LDA score Experiment Type
Kidney Failure, Chronic PRJEB65297🔗3.91664240701929mNGS
Hemangioma, Cavernous PRJNA629755🔗-4.41031173033365mNGS
Hypertension PRJNA509999🔗-4.00051914636322mNGS
Diarrhea PRJEB14038🔗-4.74793249537859mNGS
Colorectal Neoplasms PRJEB53891🔗-5.11336182007207mNGS
Colorectal Neoplasms PRJNA888860🔗-4.66383594273918mNGS
Colorectal Neoplasms PRJNA961076🔗-4.62603639856819mNGS
Colorectal Neoplasms PRJEB70916🔗-4.55528491815063mNGS
Colorectal Neoplasms PRJNA763023🔗-4.32766882364135mNGS
Colorectal Neoplasms PRJNA1138893🔗-4.15985624356077mNGS
Colorectal Neoplasms PRJNA936589🔗4.51172804013145mNGS
Colorectal Neoplasms PRJNA1050885🔗4.6850915437319mNGS
Parkinson Disease PRJEB53403🔗-4.48133980785775mNGS
Colitis, Ulcerative PRJEB42155🔗-4.80154827320187mNGS
Colitis, Ulcerative PRJNA429990🔗-4.76156330605492mNGS
Campylobacter Infections PRJNA660443🔗-4.24908686749654mNGS
Crohn Disease PRJNA793776🔗-4.99026827301931mNGS
Crohn Disease PRJEB42155🔗-4.84522170381012mNGS
Crohn Disease PRJNA813736🔗-4.48136897039431mNGS
Crohn Disease PRJNA398089🔗-4.29039494343661mNGS
Crohn Disease PRJNA993675🔗-4.23901791168084mNGS
Psoriasis PRJNA938297🔗-4.33076654568029mNGS
Arthritis, Rheumatoid PRJNA896336🔗4.60195490354935mNGS
Fatigue Syndrome, Chronic PRJNA379741🔗-4.42238835208409mNGS
Fatigue Syndrome, Chronic PRJNA878603🔗-4.17057624282374mNGS
Fatigue Syndrome, Chronic PRJNA751448🔗-3.90365647860183mNGS
Neuroblastoma PRJEB63351🔗-4.58326055166116mNGS
Neuroblastoma PRJNA716780🔗-4.48358452068433mNGS
Irritable Bowel Syndrome PRJEB37924🔗-3.95436705304651mNGS
Depressive Disorder, Major PRJNA762199🔗-4.56829117439713mNGS
Cholelithiasis PRJNA999028🔗-4.83138339066253mNGS
Cystic Fibrosis PRJNA314903🔗-4.51042460880577mNGS
Autism Spectrum Disorder PRJNA686821🔗-4.4405859032674mNGS
Biliary Atresia PRJNA730640🔗-4.98865156381889mNGS
COVID-19 PRJNA624223🔗-4.48478346350739mNGS
COVID-19 PRJNA689961🔗-4.30949518171064mNGS
COVID-19 PRJDB13214🔗-4.051336088486mNGS

Microbe-Therapeutic Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of therapeutic substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of therapeutic substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Therapeutic substance that metabolized by Faecalibacterium prausnitzii



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Therapeutic Substances that affect the Faecalibacterium prausnitzii



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)


Drug involved metabolizing or transporting reactions that are carried out by Faecalibacterium prausnitzii

ⓘ How do we get these drug reactions?

To obtain the reactions associated with therapeutic substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331] database.
Identifying Drug-Associated Reactions: Next, we extracted all reactions that are linked to therapeutic substances from these reconstructions. This involved filtering and identifying reactions specifically related to drug metabolism and transport.
Linking Reaction to Microbes: Utilizing the identified reaction related genes (UidA, Tdc etc.), we machted the corresponding drug-associated reactions to existing microbes in the reconstructions in AGORA2. We could link the presence of these genes in different microbes to the potential for those microbes to carry out the corresponding drug-related reactions.
Putative Drug Reactions: As a result, the drug reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with therapeutic substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGORA2)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGORA2, allowing access to the original .mat files. For more details, visit the AGORA2 repository.

# Model Download
1Faecalibacterium_cf_prausnitzii_KLE1255 Download
2Faecalibacterium_prausnitzii_A2_165 Download
3Faecalibacterium_prausnitzii_ERR1022279 Download
4Faecalibacterium_prausnitzii_ERR1022327 Download
5Faecalibacterium_prausnitzii_ERR1022484 Download
6Faecalibacterium_prausnitzii_ERR2221188 Download
7Faecalibacterium_prausnitzii_L2_6 Download
8Faecalibacterium_prausnitzii_M21_2 Download
9Faecalibacterium_prausnitzii_SL3_3 Download

Detailed Information of drug reactions

Metabolism
Transport
Drug Substrate Drug Metabolite Gene responsible for the reaction Reaction Description Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Substance Name Gene responsible for the reaction Reaction Description Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Herbal Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of herbal substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of herbal substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Traditional medicines/herbs/herbal compounds that metabolized by Faecalibacterium prausnitzii


Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Traditional medicines/herbs/herbal compounds that affect the Faecalibacterium prausnitzii



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)

Microbe-Dietary Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of dietary substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of dietary substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGREDA [Ref:Nature Communications, 12 (2021) 4728]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Dietary Substances alter the abundance of Faecalibacterium prausnitzii

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)





Dietary substance that metabolized by Faecalibacterium prausnitzii

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)




Dietary Substance involved metabolizing or transporting reactions that are carried out by Faecalibacterium prausnitzii

ⓘ How do we get these diet reactions?

To obtain the reactions associated with dietary substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGREDA [Ref:Nature Communications, 12 (2021) 4728] database.
Identifying Diet-Associated Reactions: Next, we extracted all reactions that are linked to dietary substances from these reconstructions. This involved filtering and identifying reactions specifically related to dietary substance metabolism and transport.
Linking Reactions to Microbes: Using the identified related genes (e.g., UidA, Tdc) for each drug metabolite reaction, we matched these reactions to microbes possessing the corresponding genes. This allowed us to link the presence of these genes in different microbes to their potential for carrying out the associated drug-related reactions.
Putative Drug Reactions: As a result, the diet reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with dietary substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGREDA)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGREDA, allowing access to the original .xml files. For more details, visit the AGREDA repository.

# Model View
1Faecalibacterium_cf_prausnitzii_KLE1255 View
2Faecalibacterium_prausnitzii_A2_165 View
3Faecalibacterium_prausnitzii_L2_6 View
4Faecalibacterium_prausnitzii_M21_2 View
5Faecalibacterium_prausnitzii_SL3_3 View

Detailed Information of diet reactions

Metabolism
Transport
Diet Substrate Enzyme Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Dietary Substance Name Reaction Name Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Environmental Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of environmental substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of environmental substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Environmental Substances that metabolized by Faecalibacterium prausnitzii



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Environmental Substances that affect the Faecalibacterium prausnitzii


Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)
ⓘ Background And User Guideline

Microbe Taxonomy level Species Quorum Sensing (QS) Language QS Language Class Total No. of QS Languages of the Species Reference (PubMed ID)


Diseases associated with the microbe Faecalibacterium prausnitzii


Microbiota Site Disease Name Disease Association Class Disease Associated Abundence Change Reference (PubMed ID)
Gastrointestinal tractAtopic dermatitisMicrobe abundance associates with diseaseIncreasePMID:26431583
Gastrointestinal tractBreast cancerMicrobe abundance associates with diseaseDecreasePMID:28094541
Gastrointestinal tractCrohn's disease(CD)Microbe abundance associates with diseaseDecreasePMID:22102318
Gastrointestinal tractCrohn's disease(CD)Microbe abundance associates with diseaseDecreasePMID:21910165
Gastrointestinal tractCrohn's disease(CD)Microbe abundance associates with diseaseDecreasePMID:20848492
Gastrointestinal tractCrohn's disease(CD)Microbe abundance associates with diseaseDecreasePMID:26789999
Gastrointestinal tractCrohn's disease(CD)Microbe abundance associates with diseaseDecreasePMID:19235886
Gastrointestinal tractCystic fibrosisMicrobe abundance associates with diseaseDecreasePMID:29232848
Gastrointestinal tractInflammatory bowel disease (IBD)Microbe abundance associates with diseaseDecreasePMID:19235886
Gastrointestinal tractInflammatory bowel disease (IBD)Microbe abundance associates with diseaseDecreasePMID:26296733
Gastrointestinal tractInflammatory bowel disease (IBD)Microbe abundance associates with diseaseDecreasePMID:24478468
Gastrointestinal tractInflammatory bowel disease (IBD)Microbe abundance associates with diseaseDecreasePMID:28039159
Gastrointestinal tractLiver cirrhosisMicrobe abundance associates with diseaseDecreasePMID:25079328
Gastrointestinal tractType 2 diabetesMicrobe abundance associates with diseaseDecreasePMID:20876719
Gastrointestinal tractUlcerative colitisMicrobe abundance associates with diseaseIncreasePMID:27217061
Gastrointestinal tractUlcerative colitisMicrobe abundance associates with diseaseDecreasePMID:27833384



Landscape of Bacteria-Substance-Disease Interaction/Association Network



ⓘ How is the network built?